NCT02773966

Brief Summary

The objective of this randomized phase III study is to test the superiority of Kypho-IORT compared to EBRT with regard of time to pain reduction in patients with painful vertebral metastases. Therefore patients will receive intraoperative radiotherapy (8 Gy with Intrabeam System/Carl Zeiss) during kyphoplasty (Arm A) or external beam radiotherapy with 30 Gy, added in 3 Gy per fraction on a conventional linear accelerator or 8 Gy single dose (only for international study centers, not permitted in Germany) (Arm B).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 16, 2016

Completed
1.5 years until next milestone

Study Start

First participant enrolled

November 12, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2020

Completed
Last Updated

July 22, 2022

Status Verified

July 1, 2022

Enrollment Period

2.3 years

First QC Date

May 4, 2016

Last Update Submit

July 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain evaluation

    Evaluation of the percentage of patients with a pain reduction of VAS-3 points after Kypho-IORT vs. EBRT at day 1 (one day after Kypho-IORT; one day after the first EBRT)

    day 1

Secondary Outcomes (4)

  • pain evaluation

    week 2, 6 weeks after start of treatment

  • local recurrence rate

    6 weeks, then after 3 months, then every 6 months up to 5 years

  • Quality of life (QoL) questionaire

    before start of therapy and then 6 weeks, then after 3 months, then every 6 months up to 5 years

  • Overall survival

    12 Months

Study Arms (2)

Arm A: Kypho-IORT

EXPERIMENTAL

balloon kyphoplasty/vertebroplasty + intraoperative radiotherapy

Radiation: Kypho-IORT

Arm B: EBRT

ACTIVE COMPARATOR

external beam radiotherapy with 30 Gy during 10 days (3 Gy/day)

Radiation: EBRT

Interventions

Kypho-IORTRADIATION

During kyphoplasty/vertebroplasty a intraoperative radiotherapy of the affected vertebrae is done with a miniature X-ray generator (INTRABEAM®, Carl Zeiss, Surgical, Oberkochen, Germany). The prescription dose will be 8 Gy in a distance of 13 mm from the isocenter of the radiation source. IORT will take about five minutes. After radiation the applicator will be removed and the operation will be finished as usual.

Arm A: Kypho-IORT
EBRTRADIATION

The external beam radiotherapy will be usually carried out as an outpatient procedure. All patients will receive a planning CT before the first irradiation. EBRT will be performed with 30 Gy, added in 3 Gy per fraction or 8 Gy single dose (only for international study centers, not permitted in Germany) on a conventional linear accelerator (LINAC).

Arm B: EBRT

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 50 years
  • Karnofsky Index ≥ 60
  • Initial pain score using the VAS ≥ 3 under standard pain medication
  • Histological or by imaging proven painful osteolytic metastases (max. 4 treatable vertebrae) of the thoracic/lumbar spine, which are accessible for Kypho-IORT
  • Written informed consent obtained

You may not qualify if:

  • Previous local treatment (irradiation, surgery)
  • Cranial site of the metastasis above T4
  • Pathological fracture with sintering \>50%
  • Purely osteoblastic metastasis
  • Intraspinal extension
  • Erosion of the bony borders of the vertebra which make a cement filling difficult, rated by the treating surgeon
  • Tumor expansion to dorsal vertebral structures (pedicle, lamina)
  • Pregnancy/lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Radiotherapy University Hospital Mannheim

Mannheim, 68167, Germany

Location

Related Publications (11)

  • Gerszten PC, Mendel E, Yamada Y. Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine (Phila Pa 1976). 2009 Oct 15;34(22 Suppl):S78-92. doi: 10.1097/BRS.0b013e3181b8b6f5.

    PMID: 19829280BACKGROUND
  • Souchon R, Wenz F, Sedlmayer F, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sautter-Bihl ML, Sauer R; German Society of Radiation Oncology (DEGRO). DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol. 2009 Jul;185(7):417-24. doi: 10.1007/s00066-009-2044-2. Epub 2009 Aug 28.

    PMID: 19714302BACKGROUND
  • Berenson J, Pflugmacher R, Jarzem P, Zonder J, Schechtman K, Tillman JB, Bastian L, Ashraf T, Vrionis F; Cancer Patient Fracture Evaluation (CAFE) Investigators. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 2011 Mar;12(3):225-35. doi: 10.1016/S1470-2045(11)70008-0. Epub 2011 Feb 16.

    PMID: 21333599BACKGROUND
  • Schneider F, Greineck F, Clausen S, Mai S, Obertacke U, Reis T, Wenz F. Development of a novel method for intraoperative radiotherapy during kyphoplasty for spinal metastases (Kypho-IORT). Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1114-9. doi: 10.1016/j.ijrobp.2010.07.1985. Epub 2010 Oct 8.

    PMID: 20934272BACKGROUND
  • Wenz F, Schneider F, Neumaier C, Kraus-Tiefenbacher U, Reis T, Schmidt R, Obertacke U. Kypho-IORT--a novel approach of intraoperative radiotherapy during kyphoplasty for vertebral metastases. Radiat Oncol. 2010 Feb 11;5:11. doi: 10.1186/1748-717X-5-11.

    PMID: 20149237BACKGROUND
  • Schmidt R, Wenz F, Reis T, Janik K, Bludau F, Obertacke U. Kyphoplasty and intra-operative radiotheray, combination of kyphoplasty and intra-operative radiation for spinal metastases: technical feasibility of a novel approach. Int Orthop. 2012 Jun;36(6):1255-60. doi: 10.1007/s00264-011-1470-9. Epub 2012 Jan 22.

    PMID: 22270861BACKGROUND
  • Reis T, Schneider F, Welzel G, Schmidt R, Bludau F, Obertacke U, Wenz F. Intraoperative radiotherapy during kyphoplasty for vertebral metastases (Kypho-IORT): first clinical results. Tumori. 2012 Jul-Aug;98(4):434-40. doi: 10.1177/030089161209800406.

    PMID: 23052158BACKGROUND
  • Bludau F, Welzel G, Reis T, Schneider F, Sperk E, Neumaier C, Ehmann M, Clausen S, Obertacke U, Wenz F, Giordano FA. Phase I/II trial of combined kyphoplasty and intraoperative radiotherapy in spinal metastases. Spine J. 2018 May;18(5):776-781. doi: 10.1016/j.spinee.2017.09.011. Epub 2017 Sep 28.

    PMID: 28962909BACKGROUND
  • Sethi A, Emami B, Small W Jr, Thomas TO. Intraoperative Radiotherapy With INTRABEAM: Technical and Dosimetric Considerations. Front Oncol. 2018 Mar 26;8:74. doi: 10.3389/fonc.2018.00074. eCollection 2018.

    PMID: 29632850BACKGROUND
  • Bludau F, Welzel G, Reis T, Abo-Madyan Y, Sperk E, Schneider F, Clausen S, Ruder AM, Obertacke U, Ghaly MM, Wenz F, Giordano FA. Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases - a randomized phase III study. BMC Cancer. 2019 May 9;19(1):430. doi: 10.1186/s12885-019-5666-5.

    PMID: 31072314BACKGROUND
  • Bludau F, Winter L, Welzel G, Obertacke U, Schneider F, Wenz F, Ruder AM, Giordano FA. Long-term outcome after combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) for vertebral tumors. Radiat Oncol. 2020 Nov 12;15(1):263. doi: 10.1186/s13014-020-01715-z.

MeSH Terms

Conditions

Neoplasm Metastasis

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Frank Giordano, MD

    Universitätsmedizin Mannheim

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Frederik Wenz

Study Record Dates

First Submitted

May 4, 2016

First Posted

May 16, 2016

Study Start

November 12, 2017

Primary Completion

March 6, 2020

Study Completion

March 6, 2020

Last Updated

July 22, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations